A Dose-finding Study for Levodopa, Carbidopa and ODM-104 Test Formulations After Repeated Administration in Healthy Males
Phase of Trial: Phase I
Latest Information Update: 09 Oct 2018
At a glance
- Drugs ODM 104 (Primary) ; Carbidopa; Levodopa
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Acronyms COMDOS1
- Sponsors Orion Pharma
- 09 Oct 2018 Results presented at the 22nd International Congress of Parkinson's Disease and Movement Disorders
- 11 Oct 2017 Status changed from recruiting to completed.
- 10 Mar 2017 Status changed from not yet recruiting to recruiting.